Alnylam Pharmaceuticals, Inc. - PE Ratio

The PE Ratio as of October 2026 (TTM) for Alnylam Pharmaceuticals, Inc. (DUL.DE) is 68.63

According to Alnylam Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 68.63. This represents a change of 12.17% compared to the average of 61.19 of the last 4 quarters.

Alnylam Pharmaceuticals, Inc. (DUL.DE) Historical PE Ratio (quarterly & annually)

How has DUL.DE PE Ratio performed in the past?

The mean historical PE Ratio of Alnylam Pharmaceuticals, Inc. over the last ten years is -11.76. The current 68.63 PE Ratio has changed -58480.73% with respect to the historical average. Over the past ten years (40 quarters), DUL.DE's PE Ratio was at its highest in in the December 2025 quarter at 70.51. The PE Ratio was at its lowest in in the June 2024 quarter at -467.92.

Alnylam Pharmaceuticals, Inc. (DUL.DE) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Alnylam Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Alnylam Pharmaceuticals, Inc. (DUL.DE) Average PE Ratio

How has DUL.DE PE Ratio performed in the past?

The current PE Ratio of Alnylam Pharmaceuticals, Inc. (DUL.DE) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Alnylam Pharmaceuticals, Inc. (DUL.DE) PE Ratio vs. Peers

How is DUL.DE’s PE Ratio compared to its peers?

Alnylam Pharmaceuticals, Inc.’s PE Ratio is greater than Arrowhead Pharmaceuticals, Inc. (-25.95), greater than Ionis Pharmaceuticals, Inc. (-12.25), greater than Wave Life Sciences Ltd. (-2.88), greater than Silence Therapeutics plc (-2.33), greater than Intellia Therapeutics, Inc. (-3.54),

Build a custom stock screener for Alnylam Pharmaceuticals, Inc. (DUL.DE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Alnylam Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Alnylam Pharmaceuticals, Inc. (DUL.DE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Alnylam Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.